World's Best Scientists 2026 revealed!
Award Badge
Psychology
Poland
2023

D-Index & Metrics

Medicine

D-Index
79
Citations
23850
World Ranking
17520
National Ranking
21

Janusz K. Rybakowski publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Janusz K. Rybakowski sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 742 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Janusz K. Rybakowski D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Janusz K. Rybakowski sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Psychology in Poland Leader Award
  • 2022 - Research.com Psychology in Poland Leader Award

Overview

Janusz K. Rybakowski is affiliated with the Poznan University of Medical Sciences in Poland. Their research primarily spans the field of medicine, with a focus on psychiatry and mental health, genetics, and biological psychiatry. Their scholarly work also touches on pediatrics, perinatology, and clinical psychology.

Their scientific contributions concentrate on several main topics:

  • Bipolar Disorder and Treatment
  • Schizophrenia research and treatment
  • Genetics and Neurodevelopmental Disorders
  • Tryptophan and brain disorders
  • Adolescent and Pediatric Healthcare
  • Electroconvulsive Therapy Studies
  • Treatment of Major Depression

Rybakowski has authored research published extensively in several journals. Frequent publication venues include:

  • Psychiatria Polska
  • Pharmacotherapy in Psychiatry and Neurology
  • Translational Psychiatry
  • The World Journal of Biological Psychiatry
  • International Journal of Bipolar Disorders

Among their recent papers are:

  • Lithium's antiviral effects: a potential drug for CoViD-19 disease? (2020) published in International Journal of Bipolar Disorders
  • Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients (2021) published in Translational Psychiatry
  • Long-Term Lithium Therapy: Side Effects and Interactions (2023) published in Pharmaceuticals
  • Antiviral, immunomodulatory, and neuroprotective effect of lithium (2022) published in Journal of Integrative Neuroscience
  • Application of Antipsychotic Drugs in Mood Disorders (2023) published in Brain Sciences

Collaborations have been an important part of their academic work, with frequent co-authors including:

  • Ewa Ferensztajn-Rochowiak
  • Claire O'Donovan
  • Mirko Manchia
  • Pablo Cervantes
  • Paul Grof

Rybakowski has also contributed to the field through book publications, with titles including:

  • Psychofarmakologia kliniczna (2022) published by Polish Scientific Publishers PWN
  • Treatment Over the Lifespan in Bipolar Disorder (2023) published by Frontiers Media

Their body of work systematically addresses clinical and genetic aspects of mood disorders, especially bipolar disorder, as well as pharmacological treatments and neurobiological mechanisms involved in psychiatric illness. The research encompasses both adult and pediatric populations, reflecting interdisciplinary attention to psychiatry, genetics, and neurodevelopmental conditions.

Best Publications

  • Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

    René S. Kahn;W. Wolfgang Fleischhacker;Han Boter;Michael Davidson

  • The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

    Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen

  • Cortical abnormalities in bipolar disorder : An MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group

    D P Hibar;L T Westlye;L T Westlye;N T Doan;N T Doan;N Jahanshad

  • Nature Reviews Disease Primers article: Wilson disease

    Anna Czlonkowska;Tomasz Litwin;Petr Dusek;Peter Ferenci

  • Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report

    Mirko Manchia;Mazda Adli;Nirmala Akula;Raffaella Ardau

  • Indicators of immune activation in major depression

    Anna Sluzewska;Janusz Rybakowski;Eugene Bosmans;Magdalena Sobieska

  • Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)

    Michael Davidson;Silvana Galderisi;Mark Weiser;Nomi Werbeloff

  • Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study

    Liping Hou;Urs Heilbronner;Urs Heilbronner;Franziska Degenhardt;Mazda Adli

  • Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine.

    A. Służewska;J. K. Rybakowski;M. Laciak;A. Mackiewicz

  • Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder: A Randomized, Double-Blind Comparison With Sertraline

    Siegfried Kasper;Göran Hajak;Katharina Wulff;Witte J G Hoogendijk

  • Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar.

    Alina Borkowska;Janusz K Rybakowski

  • Stratified medicine for mental disorders

    Gunter Schumann;Elisabeth B. Binder;Arne Holte;E. Ronald de Kloet

  • Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force Report.

    F. Kapczinski;P. V. S. Magalhães;V. Balanzá-Martinez;V. V. Dias

  • The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness

    Janusz K. Rybakowski;Katarzyna Twardowska

  • Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder.

    Liping Hou;Sarah E. Bergen;Sarah E. Bergen;Nirmala Akula;Jie Song

  • Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients.

    Janusz K Rybakowski;Alina Borkowska;Piotr M Czerski;Maria Skibińska

  • The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part III: Maintenance Treatment

    Heinz Grunze;Siegfried Kasper;Guy Goodwin;Charles Bowden

  • Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.

    René S Kahn;Inge Winter van Rossum;Stefan Leucht;Philip McGuire;Philip McGuire

  • Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: A systematic review.

    Błażej Misiak;Bartłomiej Stańczykiewicz;Kamila Kotowicz;Janusz K. Rybakowski

  • Efficacy the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: A randomized, double-blind comparison with sertraline

    S. Kasper;G. Hajak;K. Wulff;J. G. Hoogendijk

Frequent Co-Authors

Martin Alda
Martin Alda Dalhousie University
Mirko Manchia
Mirko Manchia University of Cagliari
Eduard Vieta
Eduard Vieta University of Barcelona
Michael Bauer
Michael Bauer TU Dresden
Michael Berk
Michael Berk Deakin University
Andreas J. Forstner
Andreas J. Forstner Philipp University of Marburg
Paul Grof
Paul Grof University of Toronto
Bernhard T. Baune
Bernhard T. Baune University of Münster
Leonardo Tondo
Leonardo Tondo University of Cagliari
Andreas Reif
Andreas Reif Goethe University Frankfurt

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in medicine but want to explore flexible or alternative paths, several online degree options can help you build a strong healthcare career. Many students begin with nursing, as it offers diverse entry points and career growth.

For existing registered nurses looking to advance their skills or qualify for more opportunities, affordable rn to bsn programs make it easier and cost-effective to earn a bachelor’s degree entirely online. Those who have a non-nursing background, but wish to enter the nursing field quickly, might find online direct entry msn programs especially helpful, as they fast-track non-nurses toward advanced clinical roles.

If you’re looking for a quicker start, adn nursing programs are often more accessible and can lead to RN licensure in a shorter timeframe. Not all health careers require patient care—non-clinical options like medical billing and coding are also in high demand. Recognized medical billing and coding online schools that accept financial aid offer flexibility and financial support, making a healthcare career attainable without traditional medical schooling.

Best Scientists Citing Janusz K. Rybakowski

Trending Scientists

Recently Published Articles